Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15483421 | 0.91 | TSHR (0.39) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL12688276 | 0.91 | TSHR (0.49) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL10115076 | 0.90 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9576291 | 0.88 | TSHR (0.46) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL12870020 | 0.88 | TSHR (0.54) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL11075328 | 0.87 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL11073250 | 0.87 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL9576342 | 0.87 | TSHR (0.45) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL12870021 | 0.87 | TSHR (0.57) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL12870019 | 0.86 | TSHR (0.51) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109800-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260022252-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| CN-119968408-A | Ultraviolet curable composition and use thereof | 陶氏东丽株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-119816534-A | Ultraviolet curable composition and use thereof | 陶氏东丽株式会社 | 2025-04-11 | — | — | CN | disclosed |
| CN-117897421-A | High-energy ray-curable composition and use thereof | 陶氏东丽株式会社 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024063068-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2024-03-28 | — | — | WO | disclosed |
| WO-2024063069-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | ダウ・東レ株式会社 | 2024-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109800-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | COL1A1, COL2A1, COL14A1 | TSHR 2931/4885THRB 877/4885POLB 1323/4885 |
| US-20260022252-A1 | ULTRAVIOLET-CURABLE COMPOSITION AND USE THEREOF | SEM1, COL1A1, XRCC6 | TSHR 1999/4885THRB 543/4885POLB 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.